Because CF patients with at least one F508del CFTR mutation are treated by Orkambi [33], the combination of VX-809 and VX-770, we also stimulated CHO F508del-VX-809 corrected cells with forskolin + VX-770. This evidence concerns the gene CFTR and cystic fibrosis.